Pathological Alteration in the Choroid Plexus of Alzheimer's Disease: Implication for New Therapy Approaches

Overview

Journal Front Pharmacol

Date 2012 May 8

PMID 22563316

Citations 34

Authors

Agnieszka Krzyzanowska

Eva Carro

Affiliations

Soon will be listed here.

Abstract

Morphological alterations of choroid plexus in Alzheimer's disease (AD) have been extensively investigated. These changes include epithelial atrophy, thickening of the basement membrane, and stroma fibrosis. As a result, synthesis, secretory, and transportation functions are significantly altered resulting in decreased cerebrospinal fluid (CSF) turnover. Recent studies discuss the potential impacts of these changes, including the possibility of reduced resistance to stress insults and slow clearance of toxic compounds from CSF with specific reference to the amyloid peptide. Here, we review new evidences for AD-related changes in the choroid plexus. The data suggest that the significantly altered functions of the choroid plexus contribute to the multiparametric pathogenesis of late-onset AD.

Citing Articles

Choroid Plexus Pathophysiology.

Courtney Y, Hochstetler A, Lehtinen M Annu Rev Pathol. 2024; 20(1):193-220.

PMID: 39383438 PMC: 11884907. DOI: 10.1146/annurev-pathmechdis-051222-114051.

Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studies.

Delvenne A, Vandendriessche C, Gobom J, Burgelman M, Dujardin P, De Nolf C Fluids Barriers CNS. 2024; 21(1):58.

PMID: 39020361 PMC: 11256635. DOI: 10.1186/s12987-024-00555-3.

Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems.

Loeffler D J Alzheimers Dis. 2024; 100(2):379-411.

PMID: 38875041 PMC: 11307100. DOI: 10.3233/JAD-240212.

Localized proteomic differences in the choroid plexus of Alzheimer's disease and epilepsy patients.

Leitner D, Kanshin E, Faustin A, Thierry M, Friedman D, Devore S Front Neurol. 2023; 14:1221775.

PMID: 37521285 PMC: 10379643. DOI: 10.3389/fneur.2023.1221775.

Association of Choroid Plexus Volume With Serum Biomarkers, Clinical Features, and Disease Severity in Patients With Frontotemporal Lobar Degeneration Spectrum.

Assogna M, Premi E, Gazzina S, Benussi A, Ashton N, Zetterberg H Neurology. 2023; 101(12):e1218-e1230.

PMID: 37500561 PMC: 10516270. DOI: 10.1212/WNL.0000000000207600.

References

Beal M . Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment. Neurobiol Aging. 2005; 26(5):585-6. DOI: 10.1016/j.neurobiolaging.2004.09.022. View

Reed T, Perluigi M, Sultana R, Pierce W, Klein J, Turner D . Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis. 2008; 30(1):107-20. DOI: 10.1016/j.nbd.2007.12.007. View

Serot J, Bene M, Foliguet B, Faure G . Morphological alterations of the choroid plexus in late-onset Alzheimer's disease. Acta Neuropathol. 2000; 99(2):105-8. DOI: 10.1007/pl00007412. View

Keil U, Bonert A, Marques C, Scherping I, Weyermann J, Strosznajder J . Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem. 2004; 279(48):50310-20. DOI: 10.1074/jbc.M405600200. View

Thanos C, Bintz B, Emerich D . Microencapsulated choroid plexus epithelial cell transplants for repair of the brain. Adv Exp Med Biol. 2010; 670:80-91. DOI: 10.1007/978-1-4419-5786-3_8. View

Canevari L, Clark J, Bates T . beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett. 1999; 457(1):131-4. DOI: 10.1016/s0014-5793(99)01028-5. View

Anthony S, Schipper H, Tavares R, Hovanesian V, Cortez S, Stopa E . Stress protein expression in the Alzheimer-diseased choroid plexus. J Alzheimers Dis. 2003; 5(3):171-7. DOI: 10.3233/jad-2003-5301. View

Serot J, Bene M, Faure G . Choroid plexus, aging of the brain, and Alzheimer's disease. Front Biosci. 2003; 8:s515-21. DOI: 10.2741/1085. View

Marques C, Keil U, Bonert A, Steiner B, Haass C, Muller W . Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J Biol Chem. 2003; 278(30):28294-302. DOI: 10.1074/jbc.M212265200. View

10.

Biewend M, Menke D, Calamia K . The spectrum of localized amyloidosis: a case series of 20 patients and review of the literature. Amyloid. 2006; 13(3):135-42. DOI: 10.1080/13506120600876773. View

11.

Butterfield D, Poon H, St Clair D, Keller J, Pierce W, Klein J . Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis. 2006; 22(2):223-32. DOI: 10.1016/j.nbd.2005.11.002. View

12.

Stopa E, Berzin T, Kim S, Song P, Baird A, Johanson C . Human choroid plexus growth factors: What are the implications for CSF dynamics in Alzheimer's disease?. Exp Neurol. 2001; 167(1):40-7. DOI: 10.1006/exnr.2000.7545. View

13.

Smith M, Richey Harris P, Sayre L, Beckman J, Perry G . Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci. 1997; 17(8):2653-7. PMC: 6573097. View

14.

Carro E, Trejo J, Gomez-Isla T, LeRoith D, Torres-Aleman I . Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med. 2002; 8(12):1390-7. DOI: 10.1038/nm1202-793. View

15.

Miklossy J, Kraftsik R, Pillevuit O, Lepori D, Genton C, Bosman F . Curly fiber and tangle-like inclusions in the ependyma and choroid plexus--a pathogenetic relationship with the cortical Alzheimer-type changes?. J Neuropathol Exp Neurol. 1998; 57(12):1202-12. DOI: 10.1097/00005072-199812000-00012. View

16.

Wen G, Wisniewski H, Kascsak R . Biondi ring tangles in the choroid plexus of Alzheimer's disease and normal aging brains: a quantitative study. Brain Res. 1999; 832(1-2):40-6. DOI: 10.1016/s0006-8993(99)01466-3. View

17.

Miklossy J, Taddei K, Martins R, Escher G, Kraftsik R, Pillevuit O . Alzheimer disease: curly fibers and tangles in organs other than brain. J Neuropathol Exp Neurol. 1999; 58(8):803-14. DOI: 10.1097/00005072-199908000-00003. View

18.

Alvira-Botero X, Carro E . Clearance of amyloid-β peptide across the choroid plexus in Alzheimer's disease. Curr Aging Sci. 2010; 3(3):219-29. DOI: 10.2174/1874609811003030219. View

19.

Valla J, Berndt J, Gonzalez-Lima F . Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J Neurosci. 2001; 21(13):4923-30. PMC: 6762373. View

20.

Sousa J, Cardoso I, Marques F, Saraiva M, Palha J . Transthyretin and Alzheimer's disease: where in the brain?. Neurobiol Aging. 2006; 28(5):713-8. DOI: 10.1016/j.neurobiolaging.2006.03.015. View